Stock Split History
ETFs Holding PLXP »    PLXP Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
PLx Pharma is a pharmaceutical company focused on developing its PLxGuard delivery system. Co.'s PLxGuard delivery system works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal tract. Co.'s primary product, VAZALORE 325 mg, is a formulation of aspirin using the PLxGuard delivery system to provide antiplatelet effectiveness for vascular disease prevention and treatment and reduce gastric side effects. Co. is focused on collecting the data, including initiating a bioequivalence study, required for post-approval manufacturing changes for VAZALORE 325 mg and to support approval of low dose VAZALORE 81 mg. According to our PLx Pharma stock split history records, PLx Pharma has had 1 split.
PLx Pharma stock split history picture
PLx Pharma (PLXP) has 1 split in our PLx Pharma stock split history database. The split for PLXP took place on April 20, 2017. This was a 1 for 8 reverse split, meaning for each 8 shares of PLXP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split.

When a company such as PLx Pharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the PLx Pharma stock split history from start to finish, an original position size of 1000 shares would have turned into 125 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PLx Pharma shares, starting with a $10,000 purchase of PLXP, presented on a split-history-adjusted basis factoring in the complete PLx Pharma stock split history. PLx Pharma split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/13/2014
End date: 05/17/2021
Start price/share: $112.32
End price/share: $11.17
Dividends collected/share: $0.00
Total return: -90.06%
Average Annual Total Return: -27.48%
Starting investment: $10,000.00
Ending investment: $994.47
Years: 7.18
Date Ratio
04/20/20171 for 8
PLXP is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

PMD Split History
PPHM Split History
PRAN Split History
PRGO Split History
PRPO Split History
PRSN Split History
PRTK Split History
PRXL Split History
PSTI Split History
PTIE Split History

Also explore: PLXP shares outstanding history

LM Funding America, Inc. (LMFA)
Foxby Corp. (XFXBX)
InspireMD, Inc. (NSPR)
Aviat Networks, Inc. (AVNW)
Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding PLx Pharma
PLx Pharma Insider Buying

PLx Pharma Stock Split History | | Copyright © 2013 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.